Flagship Ventures Fund IV General Partner LLC Insider Trading
Get free email notifications about insider trading for Flagship Ventures Fund IV General Partner LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Flagship Ventures Fund IV General Partner LLC. Flagship Ventures Fund IV General Partner LLC is a 10% Owner in Seres Therapeutics, Inc. ($MCRB) and a 10% Owner in Axcella Health Inc. ($AXLA) and a Director in Moderna, Inc. ($MRNA) and a 10% Owner in Evelo Biosciences, Inc. ($EVLO) and a 10% Owner in Rubius Therapeutics, Inc. ($RUBY) and a Director in Rubius Therapeutics, Inc. ($RUBY) and a 10% Owner in Kaleido Biosciences, Inc. ($KLDO) and a Director in Kaleido Biosciences, Inc. ($KLDO) and a 10% Owner in TransMedics Group, Inc. ($TMDX).
Address: 1 MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE 02142 MA
Companies in which Flagship Ventures Fund IV General Partner LLC is an Insider
Axcella Health Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner
Holdings: 4,808,780 shares
Latest Transaction: May 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Evelo Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner
Holdings: 3,207,312 shares
Latest Transaction: Feb 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kaleido Biosciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner, Director
Holdings: 1,685,444 shares
Latest Transaction: Feb 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Moderna, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund IV General Partner LLC: Director
Holdings: 14,435,589 shares
Latest Transaction: Aug 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rubius Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner, Director
Holdings: 15,393,593 shares
Latest Transaction: Mar 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seres Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner
Holdings: 4,434,600 shares
Current Value: $42,128,700
Latest Transaction: Nov 25 2020
$MCRB Market Capitalization: $374.90M
$MCRB Previous Close: $9.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TransMedics Group, Inc.
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Oct 31 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Flagship Ventures Fund IV General Partner LLC
Sentiment: All, AXLA, EVLO, KLDO, MRNA, RUBY, MCRB, TMDX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | RUBY | Rubius Therapeutic ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 29.00 | 70,000 | 2,030,000 | 2,633,703 | 2.6 M to 2.6 M (+2.73 %) |
| Mar 23 2021 | RUBY | Rubius Therapeutic ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 29.00 | 70,000 | 2,030,000 | 5,859,414 | 5.8 M to 5.9 M (+1.21 %) |
| Mar 23 2021 | RUBY | Rubius Therapeutic ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 29.00 | 70,000 | 2,030,000 | 15,393,593 | 15.3 M to 15.4 M (+0.46 %) |
| Feb 10 2021 | KLDO | Kaleido Bioscience ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 11.50 | 71,667 | 824,171 | 738,333 | 666.7 K to 738.3 K (+10.75 %) |
| Feb 10 2021 | KLDO | Kaleido Bioscience ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 11.50 | 71,667 | 824,171 | 2,982,639 | 2.9 M to 3 M (+2.46 %) |
| Feb 10 2021 | KLDO | Kaleido Bioscience ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 11.50 | 71,666 | 824,159 | 1,685,444 | 1.6 M to 1.7 M (+4.44 %) |
| Feb 04 2021 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 15.00 | 46,429 | 696,435 | 4,125,461 | 4.1 M to 4.1 M (+1.14 %) |
View all Flagship Ventures Fund IV General Partner LLC insider transactions.